The end of an era in defining the optimal treatment of invasive candidiasis.
Open Access
- 15 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (8), 1123-5
- https://doi.org/10.1093/cid/cis023
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcomeBMC Infectious Diseases, 2011
- Effects of Fluconazole, Amphotericin B, and Caspofungin on Candida albicans Biofilms under Conditions of Flow and on Biofilm DispersionAntimicrobial Agents and Chemotherapy, 2011
- Outcome Analysis of Invasive Aspergillosis in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients: The Role of Novel Antimold AzolesThe Oncologist, 2011
- PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-AnalysisJournal of Clinical Microbiology, 2011
- Breakthrough Invasive Candidiasis in Patients on MicafunginJournal of Clinical Microbiology, 2010
- Time to positive culture and identification for Candida blood stream infectionsDiagnostic Microbiology and Infectious Disease, 2009
- Severity scoring in the ICU: a reviewActa Anaesthesiologica Scandinavica, 2008
- Anidulafungin versus Fluconazole for Invasive CandidiasisNew England Journal of Medicine, 2007
- APACHE II-A Severity of Disease Classification SystemCritical Care Medicine, 1986
- APACHE IICritical Care Medicine, 1985